Tenax Therapeutics Analyst Ratings
Roth MKM Reiterates Buy on Tenax Therapeutics, Maintains $6 Price Target
Tenax Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT), Tenax Therapeutics (TENX) and Day One Biopharmaceuticals (DAWN)
Roth MKM Initiates Coverage On Tenax Therapeutics With Buy Rating, Announces Price Target of $6
Tenax Therapeutics (TENX) Receives a Buy From H.C. Wainwright
H.C. Wainwright Sticks to Their Buy Rating for Tenax Therapeutics (TENX)
No Data